🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 3 Months
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(5489)
All (5489)
Buys (554)
Sells (4935)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 14, 2026
Sale
Shares
321
Price
$500.93
Total Value
$160.80K
Shares Held After
324,443
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 14, 2026
Sale
Shares
2,148
Price
$500.05
Total Value
$1.07M
Shares Held After
324,764
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 14, 2026
Sale
Shares
3,630
Price
$499.30
Total Value
$1.81M
Shares Held After
326,912
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 14, 2026
Sale
Shares
2,130
Price
$498.39
Total Value
$1.06M
Shares Held After
330,542
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 14, 2026
Sale
Shares
537
Price
$497.22
Total Value
$267.01K
Shares Held After
332,672
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 14, 2026
Sale
Shares
414
Price
$495.96
Total Value
$205.33K
Shares Held After
333,209
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 14, 2026
Sale
Shares
320
Price
$495.02
Total Value
$158.41K
Shares Held After
333,623
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Butterfly Network, Inc.
(BFLY)
Phanstiel S. Louise
— Director
Aug 14, 2026
Purchase
Shares
115,200
Price
$8.68
Total Value
$999.51K
Shares Held After
300,461
% of Holdings
38.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
10x Genomics, Inc.
(TXG)
Teichmann Sarah A.
— Director
Aug 14, 2026
Sale
Shares
2,273
Price
$57.15
Total Value
$129.90K
Shares Held After
28,058
% of Holdings
7.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DEXCOM INC
(DXCM)
Brown Michael Jon
— EVP Chief Legal Compliance Off
Aug 14, 2026
Sale
Shares
1,700
Price
$91.93
Total Value
$156.28K
Shares Held After
102,953
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TELA Bio, Inc.
(TELA)
Getz Heather C
— Director
Aug 14, 2026
Purchase
Shares
15,000
Price
$0.70
Total Value
$10.47K
Shares Held After
520,000
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZEVRA THERAPEUTICS, INC.
(ZVRA)
Thompson Rahsaan
— Chief Legal&Compliance
Aug 14, 2026
Sale
Shares
42,666
Price
$11.13
Total Value
$474.77K
Shares Held After
37,569
% of Holdings
53.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARTIVION, INC.
(AORT)
GREEN ANDREW M
— SVP, Regulatory and Quality
Aug 14, 2026
Sale
Shares
616
Price
$28.55
Total Value
$17.59K
Shares Held After
59,643
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ARTIVION, INC.
(AORT)
Berry Lance A
— EVP, COO, CFO&Treasurer
Aug 14, 2026
Sale
Shares
715
Price
$28.55
Total Value
$20.41K
Shares Held After
210,112
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neuronetics, Inc.
(STIM)
Chernett Jorey
— 10% Owner
Aug 14, 2026
Purchase
Shares
14,000
Price
$3.16
Total Value
$44.24K
Shares Held After
10,602,988
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
Annen Steven
— SVP, Marketing&Product Mgmt.
Aug 14, 2026
Purchase
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
136,490
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
WILLSEY LANCE
— Director
Aug 14, 2026
Purchase
Shares
50,000
Price
$4.75
Total Value
$237.50K
Shares Held After
1,291,780
% of Holdings
3.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
Shah Sanket
— General Counsel&Corp Sec
Aug 14, 2026
Purchase
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
72,500
% of Holdings
6.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
Rhodes Ryan
— Director
Aug 14, 2026
Purchase
Shares
21,000
Price
$4.75
Total Value
$99.75K
Shares Held After
626,649
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
LEVINE JOSHUA
— Director
Aug 14, 2026
Purchase
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
45,000
% of Holdings
22.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
Mobeck Kenneth S.
— Chief Financial Officer
Aug 14, 2026
Purchase
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
181,610
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
Schulz Fran
— Director
Aug 14, 2026
Purchase
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
15,100
% of Holdings
66.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EDAP TMS SA
(EDAP)
Horn David R.
— Director
Aug 14, 2026
Purchase
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
10,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
40
Price
$333.23
Total Value
$13.33K
Shares Held After
50,000
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
3,095
Price
$331.43
Total Value
$1.03M
Shares Held After
50,040
% of Holdings
5.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
4,896
Price
$330.36
Total Value
$1.62M
Shares Held After
53,135
% of Holdings
8.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
7,428
Price
$329.60
Total Value
$2.45M
Shares Held After
58,031
% of Holdings
11.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
1,687
Price
$328.52
Total Value
$554.21K
Shares Held After
65,459
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
5,226
Price
$327.39
Total Value
$1.71M
Shares Held After
67,146
% of Holdings
7.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
2,287
Price
$326.60
Total Value
$746.94K
Shares Held After
72,372
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROSSI DINO A
— Director
Aug 14, 2026
Sale
Shares
341
Price
$325.60
Total Value
$111.03K
Shares Held After
74,659
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Quinlan Paul T
— General Counsel
Aug 14, 2026
Sale
Shares
3,847
Price
$111.14
Total Value
$427.55K
Shares Held After
31,034
% of Holdings
11.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Quinlan Paul T
— General Counsel
Aug 14, 2026
Sale
Shares
9,193
Price
$110.00
Total Value
$1.01M
Shares Held After
34,881
% of Holdings
20.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Quinlan Paul T
— General Counsel
Aug 14, 2026
Sale
Shares
10,200
Price
$109.11
Total Value
$1.11M
Shares Held After
44,074
% of Holdings
18.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Quinlan Paul T
— General Counsel
Aug 14, 2026
Sale
Shares
14,696
Price
$107.97
Total Value
$1.59M
Shares Held After
54,274
% of Holdings
21.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Quinlan Paul T
— General Counsel
Aug 14, 2026
Sale
Shares
10,434
Price
$107.14
Total Value
$1.12M
Shares Held After
68,970
% of Holdings
13.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oruka Therapeutics, Inc.
(ORKA)
Quinlan Paul T
— General Counsel
Aug 14, 2026
Sale
Shares
3,630
Price
$106.05
Total Value
$384.96K
Shares Held After
79,404
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CTT PHARMACEUTICAL HOLDINGS, INC.
(CTTH)
CTT PHARMACEUTICAL HOLDINGS, INC.
— CEO
Aug 14, 2026
Purchase
Shares
1,800
Price
$0.06
Total Value
$111.60
Shares Held After
9,355,456
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AbCellera Biologics Inc.
(ABCL)
Booth Andrew
— Chief Financial Officer
Aug 14, 2026
Purchase
Shares
37,200
Price
$10.32
Total Value
$383.90K
Shares Held After
482,800
% of Holdings
7.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Green Thumb Industries Inc.
(GTII/GTBIF)
Barnes Dawn Wilson
— Director
Aug 13, 2026
Sale
Shares
5,250
Price
$7.21
Total Value
$37.85K
Shares Held After
65,936
% of Holdings
7.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Medline Inc.
(MDLN)
GIC Private Ltd
— 10% Owner
Aug 13, 2026
Sale
Shares
1,500,000
Price
$35.80
Total Value
$53.70M
Shares Held After
22,902,482
% of Holdings
6.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MDxHealth SA
(MDXH)
MVM Partners, LLC
— Director
Aug 13, 2026
Purchase
Shares
2,202,643
Price
$0.45
Total Value
$1000.00K
Shares Held After
6,903,100
% of Holdings
31.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Friedl-Naderer Johanna
— Chief Commercial Officer
Aug 13, 2026
Sale
Shares
226
Price
$26.28
Total Value
$5.94K
Shares Held After
153,982
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cue Biopharma, Inc.
(CUE)
Meluzio Michael Vincent
— VP, Prin. Accounting Officer
Aug 13, 2026
Sale
Shares
3
Price
$31.13
Total Value
$93.39
Shares Held After
48,961
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cue Biopharma, Inc.
(CUE)
Meluzio Michael Vincent
— VP, Prin. Accounting Officer
Aug 13, 2026
Sale
Shares
4,106
Price
$30.35
Total Value
$124.62K
Shares Held After
48,964
% of Holdings
7.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cue Biopharma, Inc.
(CUE)
Meluzio Michael Vincent
— VP, Prin. Accounting Officer
Aug 13, 2026
Sale
Shares
1,519
Price
$29.37
Total Value
$44.61K
Shares Held After
53,070
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
OMEROS CORP
(OMER)
Borges David J.
— VP, Finance&CAO
Aug 13, 2026
Sale
Shares
5,000
Price
$16.95
Total Value
$84.75K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Butterfly Network, Inc.
(BFLY)
ROBBINS LARRY
— Director
Aug 13, 2026
Sale
Shares
175,300
Price
$8.86
Total Value
$1.55M
Shares Held After
4,371,387
% of Holdings
3.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Butterfly Network, Inc.
(BFLY)
ROBBINS LARRY
— Director
Aug 13, 2026
Sale
Shares
500,000
Price
$9.24
Total Value
$4.62M
Shares Held After
11,743,530
% of Holdings
4.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Butterfly Network, Inc.
(BFLY)
ROBBINS LARRY
— Director
Aug 13, 2026
Sale
Shares
215,233
Price
$9.54
Total Value
$2.05M
Shares Held After
12,243,530
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 151–200 of 5489 transactions (page 4 of 110)
Version: v26.7.3